2022 DMC and Expo Speakers | Healthcare Distribution Alliance

Speakers

Ameer Ali

Sr. Director, Manufacturer Operations

Cencora, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Ameer Ali

Sr. Director, Manufacturer Operations

Cencora, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- E3: Temperature Controlled Product Distribution: New Challenges, New Technology, and USP Storage Updates
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Chris J. Anderson

Director, Quality Management

Cardinal Health, Inc.
- E3: Temperature Controlled Product Distribution: New Challenges, New Technology, and USP Storage Updates
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Chris has been with Cardinal Health since 1987 in Quality and Regulatory Affairs, at both the field and corporate levels, responsible for wholesale drug distribution compliance. Over the past ten years, he has built a quality system supporting the Pharmaceutical Distribution business.

Chris led the development of the current innovative and sustainable cold chain packaging process for Cardinal Health that has been recognized through the industry through various awards, speaking invitations and publications.

In his quality role, Chris has regulatory responsibility for the quality systems that support compliance, temperature management and DSCSA regulatory support.

Chris was a member of the United States Pharmacopeia (USP) Packaging and Distribution Expert Committee Member.

He holds a Bachelor of Arts degree from Norwich University in Political Science and a Master of Arts degree in Organizational Behavior.
Eric Andrews

Pharmacy Strategic Sourcing Manager

St. Jude Children's Research Hospital
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Eric Andrews

Pharmacy Strategic Sourcing Manager

St. Jude Children's Research Hospital
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Eric Andrews is an experienced supply chain professional with a dedication to pediatric healthcare. Eric is currently a supervisor, pharmaceutical supply chain at St. Jude Children’s Research Hospital where he focuses on inventory management informatics, supply chain efficiency, and compliance-related efforts.

After spending almost a decade working with various supply chains and seeing the emergence of the DSCSA, Eric knows what matters to dispensers and how to portray that upstream. He has worked extensively with vendors, distributors, and manufacturers to ensure optimal supply chain performance and advocate for dispensers.

Eric holds a BS in management information systems from The Pennsylvania State University and an MBA from The University of Missouri.
Cathy Barbic

Associate Director, Supply Chain Projects and Compliance

Novo Nordisk Inc.
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Cathy Barbic

Associate Director, Supply Chain Projects and Compliance

Novo Nordisk Inc.
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Cathy Barbic is a Senior Manager of Supply Chain Projects and Compliance at Novo Nordisk Inc.. Cathy is responsible for managing and implementing supply chain initiatives in the US including compliance and traceability. Cathy was part of the initial lot traceability effort and co-managed the US serialization project to ensure compliance with the US Drug Supply Chain Security Act (DSCSA) requirements. Cathy works closely with US internal stakeholders, the Novo Nordisk global serialization program, solution providers, and trading partners to lead the continuing effort of compliance with DSCSA regulations. She also continues to be involved with various business areas and IT to find solutions to new challenges in serialization.

Cathy’s other responsibilities include managing a cross-functional team for new product launches and she is currently involved in many other company initiatives.

Cathy has worked for Novo Nordisk Inc. for 14 years. Prior to working in the pharmaceutical industry, Cathy worked in the consumer products industry and was a management consultant implementing ERP systems. Cathy has a BA in Business and Economics from the University of Pittsburgh.
Michele Belcher

President

National Community Pharmacists Association
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Michele Belcher

President

National Community Pharmacists Association
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- G2: State Regulator Preparation for DSCSA
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salon 8
Josh M. Bolin

Associate Executive Director for Government Affairs and Innovation

National Association of Boards of Pharmacy®
- G2: State Regulator Preparation for DSCSA
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salon 8
Josh Bolin serves as the Associate Executive Director for Federal Affairs and Strategy for the National Association of Boards of Pharmacy (NABP). Since joining NABP in 2005, Josh has worked on development of PMP InterConnect, multiple pharmacy accreditation and inspection programs, including accreditation programs for durable medical equipment and specialty pharmacy, and inspection programs for the prescription drug supply chain, sterile and nonsterile compounding and nuclear pharmacy. Josh also worked with NABP’s member boards of pharmacy to develop NABP’s Universal Inspection form and Multistate Inspection Blueprint, which are tools to assist the boards of pharmacy in conducting uniform inspections of sterile compounding facilities. Josh is currently working with NABP member boards of pharmacy on uniform processes and tools with respect to the DSCSA.
Ronald N. Bone

HDA Consultant

Ronald N. Bone Consulting LLC
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Ronald N. Bone

HDA Consultant

Ronald N. Bone Consulting LLC
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the U.S. 2013 Drug Quality and Security Act. Ron retired from McKesson Corporation where he held the position of Senior Vice President, Distribution Support. His responsibilities included Regulatory Affairs and leading McKesson's product security initiatives through the use of electronic track and trace.

Ron spent 41 years with McKesson Corporation in various operations, sales and financial management positions. He was a member of the of the GS1 Process Oversight Committee, a member of the Leadership Teams of GS1 Global Healthcare and GS1 US Healthcare, and was a member of the Industry Relations Council for the Healthcare Distribution Management Association (HDMA). In 2008, Bone testified before the U.S. House of Representatives, Energy and Commerce Committee as an industry expert on anti-counterfeiting. In 2007, he was the recipient of HDMA’s Nexus Award, which is the industry’s highest honor recognizing leadership, exemplary service and professional excellence.

Ron received his BS and MBA degrees from San Jose State University.
Joe Bowman

Director of Business Development, Third Party Logistics Services

Cardinal Health 3PL Services
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Joe Bowman

Director of Business Development, Third Party Logistics Services

Cardinal Health 3PL Services
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Andrew Boyle

Chairman, American Trucking Associations & Co-President

Boyle Transportation, an Andlauer Healthcare Group company
- A5: Economic and Regulatory Outlook for the U.S. Trucking Market
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
Andrew Boyle

Chairman, American Trucking Associations & Co-President

Boyle Transportation, an Andlauer Healthcare Group company
- A5: Economic and Regulatory Outlook for the U.S. Trucking Market
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
Andrew Boyle is co-president of Boyle Transportation, a firm that provides secure, validated transportation & logistics services to select clients in the biotech/pharmaceutical and government/defense sectors. Boyle is now a subsidiary of Andlauer Healthcare Group, a Toronto Stock Exchange-listed provider of diversified healthcare logistics services. Prior to returning to the company in 2003, Andrew was an investment banker with J.P. Morgan. He earned an MBA from Northwestern University's Kellogg School of Management and an AB from Bowdoin College, where his academic performance was undistinguished and his athletic career was underwhelming.

Andrew is the chair of the American Trucking Associations and a member of the American Transportation Research Institute’s (ATRI) board of directors and of Northwestern University Transportation Center’s business advisory committee. He’s also a trustee of Eastern Bank and serves on boards and committees of several non-profit organizations including House of Hope and The Hole in the Wall Gang Camp. He is a three time winner of the KGC’s “4th Best Looking Man” award.
John Bullock

Director, Trade and Distribution, HUB, GPO

Apellis Pharmaceuticals
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
John Bullock

Director, Trade and Distribution, HUB, GPO

Apellis Pharmaceuticals
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Ananya Chadha

Advocate, Builder

Changemaker
- Innovation to Change the World
  Tuesday, March 8, 2022 | 8:15—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Ananya Chadha

Advocate, Builder

Changemaker
- Innovation to Change the World
  Tuesday, March 8, 2022 | 8:15—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
After working in a gene-editing lab with CRISPR-cas9, Ananya Chadha developed a platform “that put genomic data on the blockchain,” allowing for anonymous uploading of genomic data to research data sets.

She has also developed various neurotech devices with sponsorship from Microsoft, like brain-controlled prosthetics, mind-controlled RC cars and MP3 players controlled with EEGs. Her brain-controlled RC car won the International Grand Prize at engineering.com's Impossible Science Challenge.

She has interned at ConsenSys, worked doing AI at IBM and the Canadian Military. Now an undergraduate student at Stanford University, she is studying neurotech engineering and finished an internship at Elon Musk's Neuralink. She also is a pilot, motorcycle license holder, and invests in startups.

Ananya won Top 29 Canadians by Refinery29, Developer 30 under 30 award, the Top 23 Women in Tech in Canada and Top 100 Most Powerful Women Canada.

She has been on the Daily Planet Show, CBC, Global News, advised companies like Wealthsimple, Morgan Stanley, and Zappos, and speaks at various conferences around the world.
Marcus Chang

Senior Product Manager

Axway
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Marcus Chang

Senior Product Manager

Axway
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Paul Chen

Sr. Director, Trade and Channel Management

Lexicon Pharmaceuticals
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Paul Chen

Sr. Director, Trade and Channel Management

Lexicon Pharmaceuticals
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Thomas Christl

Assistant Secretary for Preparedness and Response

U.S. Department of Homeland Security
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Thomas Christl

Assistant Secretary for Preparedness and Response

U.S. Department of Homeland Security
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Christopher Clement

AVP, Distribution

Apexus, LLC
- A3: Successful 340B Implementation
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Christopher Clement

AVP, Distribution

Apexus, LLC
- A3: Successful 340B Implementation
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Chris Clement has 20 years of experience in 340B, pharmaceutical distribution, and generic Rx strategies. Chris has spent the last 6 years working for the 340B Prime Vendor, Apexus, and is Director of the Prime Vendor Distribution Network consisting of 29 traditional, specialty and medical-surgical distributors. He has been a guest speaker at a number of industry conferences regarding 340B operations and implementation, and has served on the 340B University faculty. Chris is also a 340B Apexus Certified Expert (ACE).

Prior to joining Apexus, Chris built his career through 13 years with AmerisourceBergen as a subject matter expert on the generic pharmaceutical marketplace, as well as a field sales coach, trainer, analyst and key account contact. His diverse background in the wholesaler industry gives him unique insight into the generics marketplace, and in understanding the 340B supply chain.
Kim Cline

SVP, Commercialization Launch Strategy & Business Development

Two Labs Pharma Services
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Kim Cline

SVP, Commercialization Launch Strategy & Business Development

Two Labs Pharma Services
- C5: A Checklist for Launching a Specialty Drug in 2022
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salon 7
Kim’s proactive approach helps commercializing pharma companies prepare for challenges they may face along the commercialization timeline. Having worked on more than 50 specialty drug launches during her tenure, Kim helps companies understand their commercialization needs and collaborates with them on a customized approach aimed at meeting goals and producing results.

Kim holds a B.S. in International Business and a B.A. in Marketing from the University of Minnesota. Although the majority of her experience lies within Oncology and Rare Disease therapies, Kim’s expertise applies to a wide variety of specialty and non-pharmaceuticals.

Kim and her husband reside in Minneapolis with their three children. In her spare time, she enjoys reading and traveling the world with her family.
Conor Conlon

Senior Director, Key Accounts

Overhaul
- C4: A Study of Risk Management on Covid Vaccine Rollouts for the State of Texas
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 3&4
Conor Conlon

Senior Director, Key Accounts

Overhaul
- C4: A Study of Risk Management on Covid Vaccine Rollouts for the State of Texas
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 3&4
Deedre Daniel

Founder and Entrepreneur

The Interesting Conversations Company
- How to be More Interesting Than a Cell Phone
  Wednesday, March 9, 2022 | 9:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Deedre Daniel

Founder and Entrepreneur

The Interesting Conversations Company
- How to be More Interesting Than a Cell Phone
  Wednesday, March 9, 2022 | 9:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Deedre Daniel founded The Interesting Conversations Company® to help people think creatively, LAUGH, and build stronger bonds with others. Before starting this business, she spent nearly two decades at GEICO, where she rose through the ranks from call center sales associate to head the Affinity Marketing division. Her team was responsible for the marketing strategy for members of over 800 organizations using a $50 million budget. As the director of that division, she was predominantly a "paid professional schmoozer" - attending hundreds of networking events for these organizations each year. She noticed most people struggled to make lasting connections with others at these events. This universal inability to connect inspired her to create a course called How to be More Interesting Than a Cell Phone®. (A book with the same title is coming out soon!) She invented The Very Interesting Game™ to go with the course. One version of the card game is for sale on Amazon.

When COVID-19 arrived, she turned her signature talk and the card game into a virtual experience for team building and remote networking events - helping others boost optimism and get closer despite social distancing. She served as the game show host for more than 100 virtual sessions for private events with players worldwide in under a year. The Very Interesting Game Show® recently received a registered trademark, too!

Deedre is a graduate of Florida Southern College and lives in Lakeland, Florida, with her husband, Robert, their dog, Spartacus, and her active imagination. When she isn't busy making life more interesting, she writes new cards for other versions of her game and works on the 501(c)(3) she founded called T he Big Fat Tip ®. This organization enlists volunteers' help to surprise people working in the service industry with $1,000+ tips. These are Random Acts of Kindness! Deedre has extensive experience speaking at conferences and training in corporate environments and has earned a reputation for having a wild and zany sense of humor. Check out some of her videos on YouTube.
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 7, 2022 | 8:00—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Chester "Chip" Davis, Jr.

President and Chief Executive Officer

Healthcare Distribution Alliance
- Welcome Address
  Monday, March 7, 2022 | 8:00—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Chester “Chip” Davis, Jr., JD, is the President and Chief Executive Office of HDA and President of the HDA Research Foundation. HDA is the national association representing pharmaceutical distributors — the vital link between the nation’s 1,400 manufacturers and nearly 330,000 sites of care. Mr. Davis oversees HDA’s day-to-day
operations and is responsible for ensuring that the organization’s members have a strong advocacy voice in legislation, regulation and policy.

Mr. Davis joined HDA in March 2020 from the Association of Accessible Medicines (AAM), the nation’s leading trade association for manufacturers of generic and biosimilar medicines, where he served as President and Chief Executive Officer since 2015. Prior to AAM, Mr. Davis held leadership roles at the Pharmaceutical Research and Manufacturers of America and AstraZeneca, where in 2007 he was recognized as one of the
inaugural winners of the CEO Leadership Award.

Mr. Davis earned an undergraduate degree in Accounting from the University of Delaware, and a Juris Doctor from the University of Baltimore School of Law.
Matthew DiLoreto

Healthcare Distribution Alliance
- C2: State of the States, Part I
- D2: State of the States, Part II
Matthew DiLoreto

Healthcare Distribution Alliance
- C2: State of the States, Part I
- D2: State of the States, Part II
As HDA’s Senior Vice President, State Government Affairs and Alliance Development, Matthew DiLoreto coordinates HDA's nationwide state government affairs efforts, while maintaining and developing relationships with key stakeholders as well as policymakers and law makers throughout the country. Matt also coordinates closely with HDA’s members to develop, implement and execute effective advocacy strategies addressing state legislative and regulatory issues affecting the pharmaceutical supply chain.

Prior to joining the HDA team, DiLoreto served as the Senior Director of State Government Affairs for the National Community Pharmacists Association (NCPA), which represents the interests of nearly 20,000 pharmacy providers and owners nationwide. At NCPA he developed and executed the association’s state legislative strategy, while working closely with the organization’s many state and federal partners across the nation. DiLoreto also was a registered federal lobbyist and actively advanced many of NCPA's federal legislative and regulatory initiatives. During his years at NCPA, DiLoreto was responsible for supporting state efforts resulting in more than 50 enacted state laws based upon NCPA model state legislation. Such laws primarily focused on reforming pharmacy reimbursement and drug pricing practices, and on providing for a fair and accessible medication delivery marketplace.

Before moving to the Washington, D.C., area, Matt advocated for the Pennsylvania Pharmacists Association in Harrisburg, Pennsylvania, as the Director, Government Affairs and also represented the Pennsylvania Dental Association.
Anita T. Ducca

Healthcare Distribution Alliance
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Anita T. Ducca

Healthcare Distribution Alliance
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Anita T. Ducca is HDA’s Senior Vice President of Regulatory Affairs. She serves as the chief liaison and advocate on behalf of HDA with federal regulatory agencies, including FDA and DEA. She has been with the organization since 2002. Prior to joining HDA, Ducca was the Director of Regulatory Affairs for the American Red Cross Biomedical Services (ARC), where she was responsible for internal and external regulatory, compliance and health and safety. Anita also served in a regulatory advocacy capacity for the American Petroleum Institute. Earlier, she has also served on the staff of several federal regulatory agencies, including the Food and Drug Administration, the Office of Management and Budget and the Environmental Protection Agency. Ducca has a BA in Mathematics from Boston College and a MS in Biostatistics from Georgetown University.
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- D3: Supply Chain Security Case Studies: Order Fraud & Operation Vax
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
Charles H. Forsaith

Vice President, PCSC

Healthcare Distribution Alliance
- D3: Supply Chain Security Case Studies: Order Fraud & Operation Vax
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
Chuck Forsaith is the Vice President of the Healthcare Distribution Alliance’s Pharmaceutical Cargo Security Coalition (PCSC), which offers supply chain security intelligence; access to contacts from industry, government, and vendor trade disciplines; as well as education opportunities to its membership. The Coalition, which Forsaith formed in 2006, brings together professionals from a wide variety of disciplines, to monitor the security of pharmaceutical goods in transit and storage, all over the world. The PCSC became part of HDA in 2017.
Forsaith has been involved in pharmaceutical supply chain security for more than 20 years, following a career as both a New Hampshire municipal and State Police officer. He also, directed security operations for a United States military intelligence gathering installation.

He has lectured both domestically and internationally in the disciplines of supply chain and site security for such organizations as the Department of Justice, the Federal Bureau of Investigation, the U.S. Food and Drug
Administration, the Drug Enforcement Administration, the Department of Homeland Security, the Central Intelligence Agency, United States Customs, the United States Merchant Marine Academy, the Partnership for Safe Medicines, ASIS and TAPA. He is an active member of the American Society of Industrial Security, the Transported Asset Protection Association, the Overseas Security Advisory Council and the National Association of Drug Diversion Investigators.

Forsaith has either authored articles for, or been featured in articles published in The New York Times, The Wall Street Journal, the UK's London Times, Germany's Frankfurter Allgemeine Zeitung, the Financial Times, Business Week, American Shipper, Security Info Watch, Life Science Reader, Security Technology Executive, Cargo Security International and Homeland Security Today.
Justine M. B. Freisleben

Healthcare Distribution Alliance
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Justine M. B. Freisleben

Healthcare Distribution Alliance
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Justine Freisleben is Vice President of Industry Relations at the Healthcare Distribution Alliance (HDA). In this role she is responsible for the development and coordination of strategies, initiatives and projects to help healthcare distributors understand and use standards, emerging technologies and best practices to increase their efficiency and productivity in the movement of information and products throughout the healthcare supply chain. Additionally, she guides development of voluntary industry guidelines for implementing and maintaining technical standards related to product identification and electronic commerce ,and represents HDA on key work groups, particularly related to the development of standards and processes to support implementation of traceability.

Prior to this role she worked for a chemical trade association focusing on international trade advocacy and international regulatory compliance.

Justine holds a BA in government from Franklin and Marshall College and a MA/MBA from American University.
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- B2: State of the Union: 2022 Federal Policy Outlook
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salon 8
Kristen L. Freitas

SVP, Federal Government Affairs and Alliance Development

Healthcare Distribution Alliance
- B2: State of the Union: 2022 Federal Policy Outlook
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salon 8
Kristen L. Freitas is HDA’s SVP, Federal Government Affairs and Alliance Development. She is responsible for federal legislative advocacy where she develops and maintains relationships with key congressional legislators and their staff, as well as conducts direct lobbying in support of association policies and positions. Kristen also is responsible for fostering relationships with supply chain stakeholders to develop alliances supporting safe and reliable healthcare distribution in the U.S. Further, Kristen oversees the HDA Political Action Committee (PAC) and grassroots activities.

Prior to joining HDA, Freitas worked as Manager, Government Affairs for PacifiCare Health Systems, and before that, for a specialty nursing association and for the National Association for Chain Drug Stores (NACDS). Prior to NACDS, she served as a Director of Outreach for a former Member of Congress.

She holds a degree in International Relations from Michigan State University and a Master of Public Administration (MPA) from George Mason University.
Omid Ghobadi

Sr. Director, Finance & Technology

HyGen Pharmaceuticals, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Omid Ghobadi

Sr. Director, Finance & Technology

HyGen Pharmaceuticals, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salon 8
John A. Gilbert

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salon 8
John Gilbert is a Director with the law firm of Hyman, Phelps & McNamara, P.C. The firm advises and represents a broad range of clients on legal issues concerning food, drug, medical devices, biologicals, pharmacy and cosmetic law and regulation.

Mr. Gilbert advises clients extensively on legal and regulatory issues concerning controlled substances, prescription drugs and precursor chemicals. His expertise extends to all regulatory and enforcement areas on federal and state laws and regulations governing the scheduling, manufacturing, distribution, dispensing, import and export of drugs and chemicals. He has extensive knowledge of the relationship and interaction of the federal Controlled Substances Act (CSA) and state laws governing controlled substances and precursor chemicals.
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

GlaxoSmithKline
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

GlaxoSmithKline
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Gregg is currently Vice President – Manufacturer Operations & Data Services and Secure Supply Chain Lead for Cencora (formerly AmerisourceBergen). The SSC project team is delivering the Track & Trace and serialization requirements of the DSCSA. Gregg’s focus is currently on Manufacturer & Customer onboarding activities as well as DC activation for inbound scanning at receiving, returns, and exception handling while also sending outbound EPCIS messages to downstream trading partners.

Prior to AB, Gregg was the US Serialisation Lead at GSK leading the work on the DSCSA saleable returns project and developing GSK’s long-term solution for the DSCSA requirements in 2023. At GSK, Gregg held positions ranging from Analytics Reporting Manager in R&D Clinical Operations, Data Lead for the US SAP implementation, and Director of Data Quality in the Transparency Data Operations & Reporting team in Pharma Finance. Prior to GSK, Gregg worked for 6 years at Pfizer in Global Logistics & Supply in the Enterprise Data Management group focused on SAP Material Master.

Gregg has almost 25 years of experience in multiple Leadership & Senior Data roles in both the Pharmaceutical, Finance, and Software industries. Gregg holds an MBA in Management from Saint Joseph’s University’s Haub School of Business and a BS in Business Administration from Rider University. Gregg has a passion for data, systems, & business processes and strives to work towards solutions that benefit all.
Justin Guthman

National Director, Pharmacy Operations

Ascension Health
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Justin Guthman

National Director, Pharmacy Operations

Ascension Health
- E1: Perspectives from the Dispenser Community
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Ilir Ivezaj

Product Engineer

LSPedia
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Ilir Ivezaj

Product Engineer

LSPedia
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Jessica Johnston

Senior Director, Global Community Affairs

BD
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Jessica Johnston

Senior Director, Global Community Affairs

BD
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Connie Jung

Senior Advisor for Policy

U.S. Food and Drug Administration
- A1: FDA Overview and Update
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Connie Jung

Senior Advisor for Policy

U.S. Food and Drug Administration
- A1: FDA Overview and Update
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Dr. Jung is currently Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR) in FDA’s Center for Drug Evaluation and Research, Office of Compliance. Her work focuses on development of policy and regulatory strategies to improve the security and integrity of the U.S. drug supply to protect patients from counterfeit or stolen product. She received her B.S. in Pharmacy from The Ohio State University and her Ph. D. in Pharmaceutical Sciences from the University of Cincinnati. Dr. Jung joined the FDA in 1999 as a toxicology researcher in the Center for Food Safety and Applied Nutrition, and later served as a Regulatory Reviewer of bioequivalence studies in the Office of Generic Drug before working on supply chain issues.
Georg Jürgens

Manager Industry Solutions & OCI Co-Chair

Spherity, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Georg Jürgens

Manager Industry Solutions & OCI Co-Chair

Spherity, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
After graduating in Business Administration from Technical University of Munich, Georg worked as manager for a large German retailer and as product owner for a software house for supply chain management services. Joining Spherity as first employee in 2018, he is today responsible for industry solutions built on top of the Spherity Cloud Identity Wallet. Currently, Georg is rolling out the Credentialing Service for authorized trading partners to enable compliance with the US Drug Supply Chain Security Act. He represents Spherity on OCI, HDA and PDG tasks forces for DSCSA.
Kevin Karschnik

Keynote Speaker, Entrepreneur, Author

KeyPoints3
- B5: Positivity Under Pressure
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salon 7
Kevin Karschnik

Keynote Speaker, Entrepreneur, Author

KeyPoints3
- B5: Positivity Under Pressure
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salon 7
Burton Kelso

The Technology Expert

Burton Kelso, LLC
- F3: How to Help Your Company Avoid Unknown and Dangerous Cyber Threats
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salons 1&2
Burton Kelso

The Technology Expert

Burton Kelso, LLC
- F3: How to Help Your Company Avoid Unknown and Dangerous Cyber Threats
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salons 1&2
Devray Kirkland

Chief Diversity, Equity and Inclusion Officer

Cardinal Health, Inc.
- A4: DE&I Recruiting: What Should We Focus On?
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
Devray Kirkland

Chief Diversity, Equity and Inclusion Officer

Cardinal Health, Inc.
- A4: DE&I Recruiting: What Should We Focus On?
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
Devray Kirkland is vice president, Diversity and Inclusion (D&I) and chief diversity officer (CDO) for Cardinal Health, a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.

As CDO, Devray has led the development and implementation of a comprehensive, enterprise-wide diversity strategy through related programs, initiatives, and projects. He also provides direction to business segments on tactical programs and systems related to attracting, retaining, and promoting a diverse workforce. In partnership with the Cardinal Health Executive Committee and Diversity & Inclusion Council, Devray fosters critical dialogue and strategic counsel across the business to progress and sustain an inclusive work culture. He was integral in the formation of both the D&I Council and employee resource groups at Cardinal Health.

Devray joined Cardinal Health in 2012 as Director, Talent Management, for the company’s Medical segment. He also held the same position supporting the Pharmaceutical segment during his tenure.

Prior to joining Cardinal Health, Devray held numerous HR management and development roles with The Scotts Miracle-Gro company, L Brands (formerly Limited Brands), and Retail Ventures, Inc.

Rooted in community and servant leadership, Devray sits on the Board of Directors for the American Heart Association of Central Ohio and the Board of Trustees for the Mount Carmel College of Nursing. He is a long-serving member of the Alpha Phi Alpha Fraternity. He has also volunteered his time as a youth football coach in Westerville, Ohio, and for Dublin Scioto High School.
Devray holds a master’s degree in Human Resource Development from Bowie State University in Bowie, Maryland, and bachelor’s degree in Zoology Management from
Howard University in Washington, D.C. Additionally, he holds multiple certifications for both HR and D&I.

He resides in Westerville, Ohio, with his wife, Nicky, and their son, Devray II. Devray is a sports fan, loves traveling, working with the youth community, and most of all – spending time with his family.
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- D2: State of the States, Part II
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Grand Ballroom Salon 8
Leah D. Lindahl

Vice President, State Government Affairs

Healthcare Distribution Alliance
- D2: State of the States, Part II
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Grand Ballroom Salon 8
Leah Lindahl is Vice President of State Government Affairs for HDA. In this role, Lindahl provides leadership and oversight for HDA’s state legislative and regulatory activities, advocating for sound public policy that supports patient access to medicines and medical products through safe, efficient and effective distribution. Previously, she covered a 19-state region across the western U.S., most recently as Senior Director of State Government Affairs.

Prior to joining HDA in 2016, Lindahl was the Vice President of the Colorado BioScience Association (CBSA). In this role, Lindahl ensured the bioscience industry was represented to its fullest potential by managing the association’s strategic planning and implementation of public policy initiatives on the state and federal level, sponsorship retention and expansion, program planning and overall membership development activities. Before joining CBSA, Lindahl was an account executive with The Kenney Group, a regional political consulting firm, where she managed healthcare, patient advocacy and the life science industry.

Lindahl earned a bachelor's degree in Journalism and Political Science from Colorado State University.
Douglas M. Long

Vice President, Industry Relations

IQVIA
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
  Wednesday, March 9, 2022 | 9:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Douglas M. Long

Vice President, Industry Relations

IQVIA
- U.S. Pharmaceutical Market and Innovation – What’s In, What’s Out, What’s Ahead
  Wednesday, March 9, 2022 | 9:00—11:00 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Doug Long’s dedication and leadership in healthcare spans four decades. Doug has unparalleled experience and perspective on pharmaceutical distribution and the changing U.S. and global healthcare marketplace.

As Vice President of Industry Relations for IQVIA (formerly QuintilesIMS) – the world’s largest pharmaceutical information company – Doug has been a leader with the company since 1989 in implementing health databases, developing new products and fostering relationships with distributors, manufacturers, retailers and industry associations.

Doug’s annual Industry Year in Review showcases his unique perspective on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends and biotechnology.

Wholesalers, retailers, manufacturers and healthcare trade associations rely on him for guidance, direction and industry expertise. Doug is a highly sought-after industry speaker at healthcare association and trade meetings. He also serves as a permanent member of the Editorial Advisory Board of HealthCare Distributor magazine.

Doug is the recipient of several industry achievement awards –the IFPW (International Federation of Pharmaceutical Wholesalers) Leadership award (2016), the Harold W. Pratt Award, bestowed by the National Association of Chain Drug Stores (2012); the Nexus Award for Lifetime Achievement by the Healthcare Distribution Management Association (2004); and, IMS Health’s prestigious Summit Award (2003) and the Chinese Association of Pharmaceutical Commerce 2017 Award for his contributions to the Chinese Supply Chain.

Prior to IQVIA, Doug was at Nielsen Market Research for 16 years in sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and an MBA from Fairleigh Dickinson University.
Susan Lorenz-Fisher

Vice President of Corporate Responsibility & Sustainability

Cencora, Inc.
- C3: Sustainability & Decarbonization in the Healthcare Distribution Industry
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 1&2
Susan Lorenz-Fisher

Vice President of Corporate Responsibility & Sustainability

Cencora, Inc.
- C3: Sustainability & Decarbonization in the Healthcare Distribution Industry
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 1&2
Susan Lorenz-Fisher currently serves as the Vice President of Corporate Responsibility and Sustainability for AmerisourceBergen and has been with the company since January 2016. After graduating from the University of Delaware with undergraduate degrees in Biochemistry and Economics, Susan went on to earn her Master’s Degree in Sustainability from the University of Michigan, as well as a Business Certification from University of Pennsylvania’s Wharton School.

Prior to joining AmerisourceBergen, Susan spent three year as the Director of Sustainability & Global Communications at Keystone Foods, a major animal production and processing company to quick service restaurants. She also spent six years as a consultant assisting Fortune 500 companies from a variety of sectors and government entities with the development of their sustainability and social responsibility strategies. Susan received Global Reporting Initiative training partner certification and has been involved in producing, managing and validating numerous sustainability reports and disclosures.
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Nicolette Louissaint

Senior Vice President, Policy and Strategic Planning

Healthcare Distribution Alliance
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Dr. Nicolette Louissaint serves as the Senior Vice President for Policy and Strategic Planning for the Healthcare Distribution Alliance (HDA). In this role, she leads HDA’s efforts to build policies and strategic approaches to bolster supply chain resilience and reinforce the role of healthcare distributors in the healthcare ecosystem.

She previously served as the Executive Director and President of Healthcare Ready, a 501(c)(3) organization that focuses on strengthening the United States’ healthcare supply chain preparedness and response before, during and after natural disasters and disease pandemics. Under her leadership, Healthcare Ready strengthened its position as a facilitator and coordinator that improves our nation's ability to plan for and respond to threats that disrupt patient access to healthcare during crises, including COVID-19.

Prior to this, Dr. Louissaint served as the Senior Advisor to the U.S. Department of State’s Special Coordinator for Ebola during the height of the 2014 epidemic. In this role, she was responsible for coordinating international efforts and jumpstarted the diplomatic response to the epidemic. Earlier in her career, Nicolette served as a Foreign Affairs Officer in the U.S. Department of State’s Bureau of Economic and Business Affairs. As the lead officer for health intellectual property and trade issues, she developed on policies and strategies related to pharmaceutical counterfeiting, pharmaceutical trade, supply chain, climate change and other science and technology development issues.

Dr. Louissaint previously served on the Federal Emergency Management Agency’s National Advisory Council in 2019 and chaired the Equity Working Group. Her current roles also include serving on Baltimore City’s Sustainability Commission, as a board member of Project HOPE, and as a Co-Chair of theHealthcare and Public Health Sector Coordinating Council. In 2020, Dr. Louissaint was named one of The Root 100 Most Influential African Americans.

She earned her bachelor’s degrees in Chemical Engineering and Biological Sciences from Carnegie Mellon University, a PhD in Pharmacology and Molecular Sciences from Johns Hopkins University School of Medicine, and an MBA from the University of Baltimore. She completed post-doctoral fellowships at the Johns Hopkins University and the American Association for the Advancement of Science.
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Julie Malone

Regulatory Affairs Manager

Value Drug Company
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Julie Malone is the Regulatory Affairs Manager for Value Drug Company where she has been a part of the DSCSA team for the past seven years. In her role at VDC, she developed a regulatory affairs program across departments and additionally developed the DSCSA suspect and illegitimate product investigation system. A proven risk manager and ethical strategist, Julie has maintained VDC’s accreditation status through the NABP Drug Distributor program. With the ability to synthesize complex policy and high velocity issues Julie has contributed to compliant business operations and profitability. She has been an active member at HDA serving on several committees including the Technology Implementation Work Group. With over 20 years of experience in both the private and public sectors, she served on the budget and policy staff for former Florida Governor Jeb Bush, as well as an Executive Director for several state licensing boards within the Florida Department of Business and Professional Regulation. Julie holds a Master’s degree in Journalism from Regent University and a Bachelor of Science degree in Political Science from Carnegie Mellon University.
David G. Mason

Supply Chain Compliance and Serialization Lead

Novartis Pharmaceuticals Corporation
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
David G. Mason

Supply Chain Compliance and Serialization Lead

Novartis Pharmaceuticals Corporation
- C1: State of Industry Readiness for 2023
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Dave Mason is currently the AD North America Serialization – Supply Chain, supporting the implementation of DSCSA for the Novartis group. He is leading the efforts for setting up systems and processes for ESO, supply chain and commercial operations. Dave represents Novartis in trade association, PDSA and FDA public meetings. He communicates to the NTO Global Serialization team with new and existing requirements for other countries, and he assures that the validation approach is consistent within the organization and execution at the sites. Dave also supports the team to develop a global master validation and TPO rollout plan.
Michael J. McBride

Vice President, Partner Relations

Upsher-Smith Laboratories, LLC
- D4: Emerging Leaders Session: Networking (How to Develop a Team of Generous Supporters…and Have Fun Doing It!)
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Grand Ballroom Salons 3&4
Michael J. McBride

Vice President, Partner Relations

Upsher-Smith Laboratories, LLC
- D4: Emerging Leaders Session: Networking (How to Develop a Team of Generous Supporters…and Have Fun Doing It!)
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Grand Ballroom Salons 3&4
As VP, Partner Relations, Mike McBride leads the company’s efforts to grow its relationships across key customers, suppliers and business partners. His responsibilities include establishing and growing relationships with chain, wholesale and other targeted business partners; and increasing the value of targeted business partnerships to support the company’s new product development, acquisition and trade objectives.

During his more than 25-year tenure at Upsher-Smith, as the company added brand pharmaceutical products to its generic portfolio, Mike helped launch and establish new Consumer Products, Managed Markets and Institutional sales teams and shape the vision for the company’s Partner Relations efforts.

Among the products Mike has helped launch and grow are diverse specialty product lines including consumer brands AmLactin® Lotions & Creams, Slo-Niacin® Tablets and prescription brands such as Prevalite® Powder, Pacerone® Tablets, Fortical® Nasal Spray, Divigel® Topical Gel, Vogelxo® Gel and Qudexy XR Capsules.

Mike holds a B.A. in Mass Communications from the University of Wisconsin—Lacrosse.
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability. Scott leads McKesson’s Traceability Team working on implementation across McKesson’s various business units.

Scott joined McKesson in 1987 and had previous roles in Finance, Distribution Center Management and as a Regional Vice President of Distribution Operations. Scott has participated in McKesson’s integration of acquisitions over the last 16 years.

Scott has been active in HDA’s Traceability Workgroup, the HDA Industry Relations Council and participates in several committees including the FGAC, RAC and SGAC. He is tri-chair of GS1 Global Healthcare Leadership Team and is a member of the GS1 US Healthcare Executive Leadership Committee.

Scott has a BA in Accountancy and a MBA from the University of Wisconsin – La Crosse.
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Tracy Nasarenko

Vice President of Community Engagement, Healthcare

GS1 US
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Tracy Nasarenko, vice president of Community Engagement at GS1 US for Healthcare, is an accomplished leader with more than 20 years of experience in healthcare and pharmaceutical supply chain, finance, product management, marketing, and operations.

In her current role, Ms. Nasarenko leads a collaborative healthcare industry group focused on addressing supply chain challenges and meeting the requirements of regulations like the Drug Supply Chain Security Act (DSCSA). Using GS1 Standards, the most widely used supply chain standards in the world, Ms. Nasarenko guides the implementation of these standards to help the pharmaceutical industry deliver safe products to patients.

Prior to joining GS1 US, Ms. Nasarenko held several leadership positions with SPI Pharma Inc. Most recently, she served as a site general manager, overseeing end-to-end operations and performance of the entire team, where she built a culture of engagement, innovation, and collaboration.

Ms. Nasarenko earned her bachelor’s degree from Villanova University and received her Master of Business Administration from West Chester University.
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Maryann Nelson

Regulatory Manager

Cardinal Health, Inc.
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Maryann Nelson is a Regulatory Manager with Cardinal Health, Inc. responsible for developing strategies to insure supply chain integrity, preventing prescription drug diversion and complying with state and federal legislative requirements. She has over 30 years of experience in Pharmaceutical Distribution. She is actively involved with industry organizations, including HDA and GS1, focused on implementing the Track and Trace requirements of the Drug Supply Chain Security Act (DSCSA).

Ms. Nelson is a graduate of The Pennsylvania State University where she received a BS degree in Business Logistics.
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- E1: Perspectives from the Dispenser Community
- G1: Traceability Roundtables
Leon Nevers

Senior Director, Procurement and Business Development

H-E-B
- E1: Perspectives from the Dispenser Community
- G1: Traceability Roundtables
Leon Nevers is the Director of Procurement and Business Development with H-E-B Pharmacy. Leon has been engaged in retail buying and selling for a lifetime. He actively works with suppliers, employers, state and U.S. political leaders, and a variety of health care providers to provide lifestyle changes that keep Texans healthy at H-E-B.

Leon has managed direct relationships with hundreds of H-E-B suppliers of Rx, OTC, and Home Diagnostics controlling an annual budget of over $2 billion per year. He currently is Chairman of The Buyers Consortium, LLC, representing 1200 retail stores and $1 billion in Generics Purchasing opportunity with group contracting. He directs, trains, and coaches business development experts to support all aspects of procurement, immunizations, store communications, third party reimbursement, specialty pharmacy, medication therapy management and helps form strategies for business development and buying.

With extensive experience in both the pharmacy and retail industries, Leon looks for simple solutions that can make life long health improvements in a value market. He believes in serving others as a formula for personal success.
Kristi O'Malley

Senior Advisor

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Kristi O'Malley

Senior Advisor

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Tony Orosz

Assistant Director - CBP PHC Center

U.S. Customs and Border Protection
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
  Tuesday, March 8, 2022 | 3:15—4:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Tony Orosz

Assistant Director - CBP PHC Center

U.S. Customs and Border Protection
- Discussion with Experts on Pharmaceutical Supply Chain Disruptions
  Tuesday, March 8, 2022 | 3:15—4:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Mr. Orosz began working for CBP in 1995 as a Customs Inspector at JFK Airport in New York. During his time at JFK he was a member of the Anti-Terrorism Contraband Enforcement Team and was a National Instructor for Customs and Border Protection.

Mr. Orosz has been with the C-TPAT program since its inception in 2003 and served as a supervisor in the C-TPAT Newark Field Office. He is now currently assigned as an Assistant Director in the newly established Pharmaceutical, Health and Chemical Center of Excellence and Expertise in New York City.
Karrah Pacheco

Senior Portfolio Executive

Apexus, LLC
- A3: Successful 340B Implementation
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Karrah Pacheco

Senior Portfolio Executive

Apexus, LLC
- A3: Successful 340B Implementation
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 1&2
Karrah Pacheco, MBA, is a Senior Portfolio Executive for Apexus, the 340B Prime Vendor. In this role, Ms. Pacheco is responsible for several key distributor relationships, including contract negotiations, education, and escalation support. She also manages generic Rx strategies for the Prime Vendor Distribution Network, which consists of 26 traditional, specialty, and medical–surgical distributors.

Ms. Pacheco has more than 15 years of experience in pharmacy and supply chain negotiations and consulting. Before assuming her role with Apexus, she served as a director of clinical services with Texas Health Resources and a senior advisor for consulting services with Vizient.

Ms. Pacheco received her MBA from the University of Texas at Tyler. She is also a Certified Pharmacy Technician and a 340B Apexus Certified Expert (ACE).
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Tish E. Pahl

Principal

Olsson Frank Weeda Terman Matz PC
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Tish Eggleston Pahl is a principal at Olsson Frank Weeda Terman Matz PC. She is regulatory counsel to drug, cosmetic, dietary supplement and food clients with concerns before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. Her work has encompassed representation of companies making and marketing human and animal prescription and over-the-counter (OTC) drugs, dietary supplements, and cosmetics. She has particular expertise in the areas of health care communications, advertising and labeling of FDA-regulated products. Further, she advises trade association clients on a range of antitrust and trade regulation issues.

Since November 2013, Tish has been heavily involved with implementation of the Drug Quality and Security Act (DQSA). She has advised pharmacy compounders and outsourcing facilities on their new FDA responsibilities under Title I of the DQSA. She has worked closely with pharmaceutical supply chain stakeholders, including manufacturers, repackagers, and wholesale distributors, on implementation of Title II of the DQSA, the Drug Supply Chain Security Act (DSCSA).

Tish is a regular participant in HDA activities, providing FDA regulatory and antitrust counsel to the Public Policy Council, the Traceability Implementation Work Group, the Regulatory Affairs Committee, the Returns Task Force, and other committees.

Tish graduated from Northwestern University and earned her Juris Doctor from Northwestern University (cum laude).
Karla Palmer

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salon 8
Karla Palmer

Director

Hyman, Phelps, and McNamara, P.C.
- F2: Controlled Substances Legal Panel
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Grand Ballroom Salon 8
With over 25 years’ experience as a litigator, Karla’s focus at Hyman Phelps is on DEA and FDA enforcement and litigation matters. Karla also advises clients throughout the supply chain - from manufacturers and distributors to outsourcing facilities, pharmacies and doctors - on a range of issues including DEA and FDA regulations and guidance, government inspections (including Form 483s) and investigations, warning letters, consent decrees, and administrative and federal proceedings. In addition, she has written about and addressed industry audiences on all aspects of the passage and implementation of the 2013 Drug Quality and Security Act including both compounding and supply chain issues, its guidance documents, and implementing regulations. She is well-versed on the DSCSA and on compounding laws, regulations and guidance, and regularly counsels clients throughout the nation on these matters.
John E. Parker

Senior Vice President, Communications and Marketing

Healthcare Distribution Alliance
- E4: Health Delivered: Telling the Distribution Sector Value Story
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
John E. Parker

Senior Vice President, Communications and Marketing

Healthcare Distribution Alliance
- E4: Health Delivered: Telling the Distribution Sector Value Story
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
John Parker is a seasoned strategic communications and marketing professional with broad leadership experience and progressive management and operational responsibilities. Throughout his career, he has represented sectors from across the healthcare spectrum, while working for major trade associations and a Fortune 20 company. John has worked extensively with national and trade media to advance major public health and wellness initiatives, shaped the debate on the most pressing policy issues facing the country, and navigated through periods of crisis resulting from legislative and legal scrutiny. Notably, for the past decade, John has played a central role in how his organizations responded to health reform, the opioid crisis and COVID-19.

John currently serves as the Senior Vice President of Communications and Marketing for the Healthcare Distribution Alliance (HDA), the national organization representing pharmaceutical distributors and the healthcare supply chain. Prior to joining HDA, John spent nearly a decade in communications leadership roles with the Blue Cross and Blue Shield Association and UnitedHealth Group. His work in the health insurance industry was preceded by a stint at the Association of American Medical Colleges, where he served as the primary spokesperson with the media on key issues in academic medicine and managed the association's external publications. John’s initial exposure to communications was as an editor and reporter for one of the leading publishers of trade newsletters following FDA and its regulation of the drug and device industries and NIH.

John serves on the Board of Directors of the Arlington Free Clinic, an organization in northern Virginia dedicated to providing healthcare services to uninsured and underinsured adults.

John graduated from the University of Wisconsin-Madison.
Bradley T. Pine

Smith Drug Company, Div. J M Smith Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Bradley T. Pine

Smith Drug Company, Div. J M Smith Corporation
- D1: Preparing for DSCSA: Distributors’ Perspectives
  Monday, March 7, 2022 | 3:30—4:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Brad Pine is currently Vice President, Brand Pharma & Regulatory for Smith Drug Company; he has over 30 years of experience in the pharmaceutical wholesale industry. Brad's industry experience includes working for national and regional wholesalers; his breadth of knowledge comprises regulatory compliance, branded pharmaceuticals, consumer goods, marketing and overall business operations.

Brad is responsible for oversight of Branded Manufacturer Agreements, regulatory implementation, Distribution Center SOPs, and business strategies. He has been involved in implementing the Drug Supply Chain Security Act (DSCSA) at Smith Drug Company and is an active member on HDA's Traceability Implementation Work Group since its inception in November 2013.

He is an active member on HDA committees, including the Federal Government Affairs, Regulatory Affairs, and State Government Affairs Committees.

Brad holds a BS degree in Finance from Indiana University.
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Thomas W. Prevoznik

Assistant Administrator, Diversion Control Division

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Acting Assistant Administrator (DAA) Thomas W. Prevoznik began his career with the Drug Enforcement Administration (DEA) in February 1991. Upon his graduation from Basic Diversion Investigator Training, DAA Prevoznik was assigned as a Diversion Investigator (DI) to the Philadelphia Field Division. After serving in many supervisory roles in the Philadelphia Field Division, New Jersey Field Division, and DEA Headquarters, in August 2019, he was promoted to the Senior Executive Service as DAA of the Diversion Control Division.

DAA Prevoznik is a graduate from the University of Notre Dame, with a Bachelor of Arts in 1987; and the University of Virginia, with a Masters in Adult Education in 2004.
Senthil S. Rajaratnam

Director, Global Serialization and UDI

Lilly USA, LLC
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Senthil S. Rajaratnam

Director, Global Serialization and UDI

Lilly USA, LLC
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Senthil Rajaratnam is the Director for Global Serialization and UDI implementation. In his role, Senthil leads the global strategy and implementation for serialization and product traceability for pharmaceutical products and Unique Device Identification implementation for medical devices. Senthil coordinates with the Lilly’s affiliate offices, packaging sites, engineering and IT teams to implement the right solutions to ensure compliance with serialization/UDI marking and reporting requirements.

Senthil has been with Eli Lilly and Company for 20 years. Senthil’s key expertise includes packaging line equipment and systems, warehousing, distribution and logistics area of the supply chain and has deep knowledge in the business processes and solutions in this space. He is also the subject matter expert on GS1 standards and is part of various industry workgroups that work towards a common goal of providing advocacy to influence the adoption of global standards, harmonizing requirements and help governments achieve their goals leveraging serialization. He is currently on the Board of Directors for Partnership for DSCSA Governance (PDG) and also part of the Healthcare Leadership team of GS1 Healthcare Global organization.
Alexandra M. Romero

Partner

ArentFox Schiff LLP
- B4: Workplace Safety in the Time of Covid-19
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 3&4
Alexandra M. Romero

Partner

ArentFox Schiff LLP
- B4: Workplace Safety in the Time of Covid-19
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 3&4
Alexandra Romero is an associate within the Labor & Employment and OSHA groups and focuses her practice on representing employers in all aspects of the Occupational Safety and Health Act and state and federal employment laws. She has represented clients in numerous industries during agency proceedings, proposed rulemakings, mediations, arbitrations, and all phases of state and federal court litigation. This representation includes counseling clients regarding compliance with OSHA standards and regulations, investigating workplace incidents, contesting OSHA citations, defending employers in OSHA enforcement actions, and engaging in regulatory advocacy.
Courtney Romolt

Healthcare Ready
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Courtney Romolt

Healthcare Ready
- G3: Coordinating During Crisis: Effective Partnerships for Supply Chain Resilience
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Grand Ballroom Salons 1&2
Courtney Romolt is the Programs Manager at Healthcare Ready, where she provides management and leadership for the organization’s programmatic projects. Courtney leads on the organization’s supply chain and critical healthcare infrastructure focus areas and supervises the work of the Programs Team. Courtney provides incident response support for Healthcare Ready’s emergency activations, and has supported the organization’s response to many major events including Hurricane Florence, the Carr Fire, Hurricane Ida, and COVID-19.

Before joining Healthcare Ready, Courtney worked with the World Resources Institute’s Initiative 20×20 to promote the business case for landscape restoration in Latin America and the Caribbean. Prior to this, she researched the environmental effects, economic trends, and regulatory framework of enhanced oil recovery as a Graduate Consultant for the NGO Clean Water Action.

Courtney holds a Masters of Arts in International Economics and Energy, Resources and the Environment from the Johns Hopkins School of Advanced International Studies, where she also earned a Graduate Certificate in Chinese and American Studies. Courtney also holds undergraduate degrees in Integrative Biology and Global Studies from the University of Illinois at Urbana-Champaign.
Michael Rowe

Director, DSCSA/Serialization Services

Two Labs Pharma Services
- C5: A Checklist for Launching a Specialty Drug in 2022
- G1: Traceability Roundtables
Michael Rowe

Director, DSCSA/Serialization Services

Two Labs Pharma Services
- C5: A Checklist for Launching a Specialty Drug in 2022
- G1: Traceability Roundtables
Matt Sample

SVP, Manufacturer and Replenishment Operations

Cencora, Inc.
- C1: State of Industry Readiness for 2023
- D1: Preparing for DSCSA: Distributors’ Perspectives
Matt Sample

SVP, Manufacturer and Replenishment Operations

Cencora, Inc.
- C1: State of Industry Readiness for 2023
- D1: Preparing for DSCSA: Distributors’ Perspectives
Matt Sample is the Vice President of Manufacturer Operations at AmerisourceBergen. He is responsible for the maintenance of vendor and item master data, driving the adoption of supply chain standards internally and with manufacturer trading partners, and leading the implementation of DSCSA across all AmerisourceBergen business units. In addition to the core drug distribution business responsibilities, Matt is responsible for the DSCSA serialization efforts within their pharmaceutical manufacturing and repackaging businesses and leads our Covid19 Therapies operations efforts with the United States Government.

He has over 17 years of experience in the medical device, pharmaceutical and life sciences industry, working both for manufacturers, wholesalers and for a large consulting firm. He has held various roles in the areas of product development, lean six sigma, business system implementation and operational leadership. Prior to joining AmerisourceBergen, Matt was the serialization program lead at a mid-size pharmaceutical company, and the UDI program manager a large medical device manufacturer.
Farah M. Simonett

Vice President, Communications and Marketing

Healthcare Distribution Alliance
- E4: Health Delivered: Telling the Distribution Sector Value Story
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
Farah M. Simonett

Vice President, Communications and Marketing

Healthcare Distribution Alliance
- E4: Health Delivered: Telling the Distribution Sector Value Story
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salons 3&4
Farah Simonett is a communications, marketing and creative services professional with more than 15 years of progressive experience in not-for-profit healthcare and membership organizations.

As the Healthcare Distribution Alliance’s (HDA) Vice President of Communications and Marketing, Farah serves as primary content strategist, executive speechwriter, media spokesperson and editor-in-chief for the national association representing healthcare distributors. HDA members are the vital link between 1,400 manufacturers and nearly 330,000 providers, delivering more than 11 million medicines and healthcare products safely and reliably each day.

Since joining HDA in 2008, Farah has led numerous communications and marketing programs across the association, including the rebranding of HDA, the launch of the organization’s award-winning Health Delivered campaign and Allied Against Opioid Abuse initiative. She is a trusted advisor with the proven ability to lead teams under pressure, on deadline and through crisis.

Farah is passionate about communicating to audiences across a range of mediums.Most recently, she has directed efforts to spotlight the distribution industry’s value proposition through enhanced storytelling and member engagement. Over the past few years, she has covered HDA members' response to the COVID-19 crisis as well as launched the association’s Faces of the Supply Chain video series. Further, she created (and now spearheads) HDA’s internal communications program.

Farah’s first exposure to the healthcare industry was through working in HIV/AIDS-related clinical trials at Georgetown University Medical Center in Washington, D.C. She graduated from The College and William and Mary in Virginia.
Matthew Strait

Deputy Assistant Administrator

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Matthew Strait

Deputy Assistant Administrator

U.S. Drug Enforcement Administration (DEA)
- A2: Break-Out Discussion with the Drug Enforcement Administration
  Monday, March 7, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Mr. Matthew J. Strait is a 20 year veteran of the Drug Enforcement Administration (DEA). His contributions to the DEA spans several regulatory roles specifically relating to entities authorized to possess controlled substances, currently surpassing 1.85 million nationwide. These roles include such activities as: importation, exportation, manufacture, distribution, prescribing, and dispensing.

Since 2017, Mr. Strait serves as chief policy advisor for the Diversion Control Division. He is the senior advisor to the Assistant Administrator on a broad range of policy issues impacting the DEA’s vast registrant population.

From 2015 - 2017, Mr. Strait directed day-to-day operations of DEA’s Congressional Affairs Section. The section responsible for assistance to the United States Congress on comprehensive legislation action. From 2009 to 2015, Mr. Strait served in the Congressional Affairs Section as a liaison where he worked to address important policy goals, including: drug disposal, synthetic drugs, anabolic steroids, quotas, and access to controlled substances by emergency medical professionals.

From 2004 - 2009, Mr. Strait served as the Unit Chief of DEA’s Quota and UN Reporting Unit. The unit responsible for oversight and adjudication of quota applications filed by DEA-registered manufacturers of schedule I and II controlled substances. Prior to 2004, Mr. Strait served as a Drug Science Specialist in the DEA’s Drug and Chemical Evaluation Section. This section began his DEA career in 1999 and where he fulfilled many of DEA’s reporting obligations pursuant to various United Nations’ treaties.

Mr. Strait graduated from the Virginia Polytechnic Institute and State University, Virginia Tech with both a Bachelor (’95) and Master of Science (’97) degrees.
Ben Taylor

CEO

LedgerDomain, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Ben Taylor

CEO

LedgerDomain, Inc.
- G1: Traceability Roundtables
  Tuesday, March 8, 2022 | 2:00—3:00 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Stephanie Trunk

Partner

ArentFox Schiff LLP
- E2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Stephanie Trunk

Partner

ArentFox Schiff LLP
- E2: Overview of the Rapidly Shifting Reimbursement Policy Landscape
  Tuesday, March 8, 2022 | 10:00—11:00 AM
  
  JW Grand Ballroom Salon 8
Stephanie Trunk is a partner in the Health Law Group at Arent Fox LLP in Washington, D.C. Ms. Trunk counsels pharmaceutical and device manufacturers, distributors and their customers on regulatory, reimbursement and compliance matters. Her practice extends to counseling on drug pricing and government price reporting, HIPAA and privacy matters, counseling on Medicare Part D, developing corporate compliance programs, representing clients in contract negotiations and providing transactional support to her clients.

Prior to joining Arent Fox LLP, Ms. Trunk was in-house counsel to a pharmacy benefit management company. Ms. Trunk is the author of numerous chapters in health law treatises including a chapter on Controlling Fraud, Waste and Abuse in the Medicare Part D Program in the ABA/BNA's Health Care Fraud and Abuse: Practical Perspectives.

She received a JD with Highest Honors from the George Washington University Law School in 2003. Ms. Trunk also has a graduate certificate in health management from the George Washington University School of Public Health (2003) and she received a BS in Accounting Summa Cum Laude from the University of Maryland in 1997.
Tim Urban

Writer

Wait But Why
- Why Procrastinators Procrastinate: The Never-Ending Battle in Our Heads
  Monday, March 7, 2022 | 8:00—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
Tim Urban

Writer

Wait But Why
- Why Procrastinators Procrastinate: The Never-Ending Battle in Our Heads
  Monday, March 7, 2022 | 8:00—9:30 AM
  
  JW Marriott Grand Ballroom Salons 5&6
As the creative force behind the extremely popular “Wait But Why” blog, Tim Urban has authored dozens of viral articles on subjects ranging from why we procrastinate to why we have not yet encountered alien life forms. “Wait But Why” has topped 10 million unique visitors and attracted thousands of readers.

Known for delighting audiences with smart, fascinating and truly original content, Tim synthesizes complex concepts and presents them in a humorous, highly entertaining and memorable way. Follow his spellbinding train of thought to ignite your own insights and energize your thinking. Whatever the topic, Tim makes getting there more than half the fun.
Elizabeth Waldorf

Director, Global Traceability and Standards

TraceLink Inc.
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Elizabeth Waldorf

Director, Global Traceability and Standards

TraceLink Inc.
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Elizabeth Waldorf is Director of Global Traceability and Standards at TraceLink. She is responsible for transforming global regulatory serialization and traceability regulations into product requirements for TraceLink’s portfolio of track and trace solutions. Elizabeth is a key contributor to TraceLink’s delivery of US, Brazil, China, South Korea, EU, Russia, India, Bahrain, Indonesia, Uzbekistan, and Kazakhstan government compliance modules. Elizabeth is focused on transforming country regulations into standardized models for traceability implementations.

Starting before the US DSCSA regulation was passed, Elizabeth has been driving pharmaceutical compliance at the state level. Her effort has continued through the passing of the US DSCSA regulation to the present day. A believer in achieving interoperability and operational efficiency through standards, Elizabeth’s editorial contributions include the following guidelines: “GS1 US Implementation Guideline for Applying GS1 Standards for DSCSA and Traceability (release 1.2)”, “GS1 US Implementation Guideline for the GS1 Lightweight Messaging Standard for Verification of Product Identifiers (releases 1.0, 1.1 and 1.2)”, and “GS1 US Applying GS1 System of Standards to Pharmaceutical Chain of Custody (releases 1.0 and 1.1)”. With a vigilant eye towards accelerating onboarding of trading partners for DSCSA message exchanges using EPCIS, Elizabeth collaborated to develop the GS1 US Rx EPCIS Conformance Testing Program. Committed to industry pharmaceutical compliance readiness, she is working towards the development of future releases of implementation guidelines to reflect evolved requirements and learnings.

With a passion for thought leadership, Elizabeth joined the GS1 US Healthcare Executive Leadership team and has taken on various leadership roles spanning GS1 US and GS1 Global. She currently co-chairs the GS1 US Rx Secure Supply Chain workgroup and GS1 EPICS/CBV 2.0 MWSG. As a member of GS1 Architecture team, Elizabeth serves as the GS1 Architecture liaison to GS1 Mission Specific Workgroups for EPICS/CBV 2.0, Pharmaceutical Clinical Trial Processes and Biological Samples. Elizabeth previously co-chaired the GS1 Brazil Traceability, Global Traceability Standard, and the GS1 Lightweight Messaging Standard workgroups.

Elizabeth is also an active leader in other industry and standards organizations including Partnership for DSCSA Governance (PDG), Healthcare Distribution Alliance (HDA) and serves as tri-chair of the Open Credentialing Initiative (OCI)’s Policy and Architecture team. She brings together her multi-discipline experience to advance and accelerate the delivery of specifications and adoption of interoperable standards. Before joining TraceLink, Elizabeth led Amgen’s global serialization and traceability initiatives, and drove adoption of GS1 standards across the company. In her 20-year tenure at Amgen, Elizabeth held numerous senior leadership roles managing cross functional teams in Global Supply Chain, Sales & Marketing, Enterprise Architecture, and Finance. Her leadership style and operational excellence mindset combined with business and information systems background have resulted in many successful implementations of process re-engineering and automation initiatives.
Sharon Webster

AD, Market Product Quality

Sandoz
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Sharon Webster

AD, Market Product Quality

Sandoz
- F1: Best Practices Around Manufacturer Data Quality
  Tuesday, March 8, 2022 | 11:15—12:15 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Wayne Williams

Executive Director

Coldchain Technology Services
- C4: A Study of Risk Management on Covid Vaccine Rollouts for the State of Texas
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 3&4
Wayne Williams

Executive Director

Coldchain Technology Services
- C4: A Study of Risk Management on Covid Vaccine Rollouts for the State of Texas
  Monday, March 7, 2022 | 2:15—3:15 PM
  
  JW Grand Ballroom Salons 3&4
Andrew L. Wilson

Vice President, 340B Solutions

McKesson Corporation
- B3: 340B Update
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 1&2
Andrew L. Wilson

Vice President, 340B Solutions

McKesson Corporation
- B3: 340B Update
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 1&2
Andrew Wilson is Vice President for 340B Solutions with McKesson. He is responsible for guiding and coordinating McKesson 340B strategy and business oversight.

Andy has over 25 years of healthcare operations experience as a pharmacy leader in academic medical centers and integrated health systems. He has extensive 340B experience and has served as a member of the Executive Committee of the Safety Net Hospitals for Pharmaceutical Access (now 340B Health) and as Chair of the Hospital Advisory Board of the 340B Prime Vendor Program (Apexus).

Andy is the author of over 60 articles, book chapters and editorials in the medical and pharmacy literature including Financial Management for Health–System Pharmacists (2008). He has spent the past ten years leading consulting teams providing pharmacy management, operations and financial advisory services with a focus on 340B.
Herbert Wong

SVP Product & Strategy

Antares Vision Group
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Herbert Wong

SVP Product & Strategy

Antares Vision Group
- B1: EPCIS Standards and Implementation Progress
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Marriott Grand Ballroom Salons 5&6
Heather Zenk

President, US Supply Chain

Cencora, Inc.
- B4: Workplace Safety in the Time of Covid-19
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 3&4
Heather Zenk

President, US Supply Chain

Cencora, Inc.
- B4: Workplace Safety in the Time of Covid-19
  Monday, March 7, 2022 | 11:30—12:30 PM
  
  JW Grand Ballroom Salons 3&4
Heather Zenk, R.Ph., PharmD., is President of the US Supply Chain, Cencora. In this role, she has responsibly for the entire distribution network of human and animal health products, as well as developing and implementing traceability business processes and technology that will enhance patient safety, further secure the pharmaceutical supply chain, and create broader service offerings to manufacturer partners and Cencora customers. In addition, Heather also manages customer support, business enablement efforts, in addition to replenishment and manufacturer operations covering manufacturer programs and data.

Heather’s combination of operational skills and business acumen uniquely positioned her to lead Cencora’s COVID-19 response team. In this capacity, she served as a vital resource to our associates, hospital systems and dispenser customers, as well as our manufacturer partners helping them navigate the complexities that COVID-19 brought to the pharmaceutical supply chain.

Heather has 20 years of pharmacy, procurement, distribution, and supply chain experience, which she has utilized in her career at Cencora including that of SVP, Replenishment and Manufacturer Operations, Vice President, Distribution Center Manager at the Chicago Distribution Center, SAP business liaison; and running operations at the Canadian Distribution network.

Heather received a Bachelor of Arts degree from the College of St. Benedict, St. Joseph, MN, and a Doctorate of Pharmacy degree from the University of Minnesota.

Registration and Hotel Information

Genesis Argueta
Sponsorship Opportunities

Lisa Kanfer
Exhibit Opportunities

Michelle Leslie
Membership

Lisa Gallagher
Conference Schedule, Speaker Information, and Education Content

Subrina Ghorashi

2022 Distribution Management Conference and Expo

March 6-9, 2022 | JW Marriott Austin, TX

Speakers

Ameer Ali

Ameer Ali

Chris J. Anderson

Chris J. Anderson

Eric Andrews

Eric Andrews

Cathy Barbic

Cathy Barbic

Michele Belcher

Michele Belcher

Josh M. Bolin

Josh M. Bolin

Ronald N. Bone

Ronald N. Bone

Joe Bowman

Joe Bowman

Andrew Boyle

Andrew Boyle

John Bullock

John Bullock

Ananya Chadha

Ananya Chadha

Marcus Chang

Marcus Chang

Paul Chen

Paul Chen

Thomas Christl

Thomas Christl

Christopher Clement

Christopher Clement

Kim Cline

Kim Cline

Conor Conlon

Conor Conlon

Deedre Daniel

Deedre Daniel

Chester "Chip" Davis, Jr.

Chester "Chip" Davis, Jr.

Matthew DiLoreto

Matthew DiLoreto

Anita T. Ducca

Anita T. Ducca

Charles H. Forsaith

Charles H. Forsaith

Justine M. B. Freisleben

Justine M. B. Freisleben

Kristen L. Freitas

Kristen L. Freitas

Omid Ghobadi

Omid Ghobadi

John A. Gilbert

John A. Gilbert

Gregg A. Gorniak

Gregg A. Gorniak

Justin Guthman

Justin Guthman

Ilir Ivezaj

Ilir Ivezaj

Jessica Johnston

Jessica Johnston

Connie Jung

Connie Jung

Georg Jürgens

Georg Jürgens

Kevin Karschnik

Kevin Karschnik

Burton Kelso

Burton Kelso

Devray Kirkland

Devray Kirkland

Leah D. Lindahl

Leah D. Lindahl

Douglas M. Long

Douglas M. Long

Susan Lorenz-Fisher

Susan Lorenz-Fisher

Nicolette Louissaint